Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13063-017-2228-5
Published Online: 2017-10-25
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Wu, Wei
Deng, Heran
Rao, Nanyan
You, Na
Yang, Yaping
Cao, Minghui
Liu, Jieqiong
Funding for this research was provided by:
Sun Yat-Sen University Clinical Research 5010 Programme (2016015)